Search research articles
Contact Us
Filters
Showing results (131-140 of 156) with videos related to
Page
of 16
Sort By:
Journal of the National Cancer Institute
|
August 19, 1992
Antiproliferative and antitumor activity of the 2-cyanoaziridine compound imexon on tumor cell lines and fresh tumor cells in vitro
E M Hersh, C R Gschwind, C W Taylor, et al.
Journal of the American Chemical Society
|
July 18, 2001
Design and synthesis of a novel DNA-DNA interstrand adenine-guanine cross-linking agent
Q Zhou, W Duan, D Simmons, et al.
Life Sciences
|
January 1, 1996
Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study
R T Dorr, R Lines, N Levine, et al.
Journal of Medicinal Chemistry
|
February 13, 1999
Novel antitumor 2-cyanoaziridine-1-carboxamides
B S Iyengar, R T Dorr, D S Alberts, et al.
Journal of Medicinal Chemistry
|
April 12, 1996
6- and 7-substituted 2-[2'-(dimethylamino)ethyl]-1,2-dihydro-3H-dibenz[de,h] isoquinoline-1,3-diones: synthesis, nucleophilic displacements, antitumor activity, and quantitative structure-activity relationships
S M Sami, R T Dorr, A M Sòlyom, et al.
European Journal of Immunology
|
May 1, 1989
Alpha-globulins suppress human leukocyte tumor necrosis factor secretion
P Scuderi, R T Dorr, J D Liddil, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1992
Cardiotoxicity of mitomycin A, mitomycin C, and seven N7 analogs in vitro
R T Dorr, N G Shipp, J D Liddil, et al.
Journal of Medicinal Chemistry
|
August 1, 1987
New antitumor agents containing the anthracene nucleus
T P Wunz, R T Dorr, D S Alberts, et al.
Anti-Cancer Drugs
|
February 1, 1991
In vitro cytotoxicity against fresh human tumors and P388 leukemia predicts the differential in vivo activity of a series of anthracene anticancer drugs
D S Alberts, R T Dorr, T P Wunz, et al.
Life Sciences
|
January 1, 1988
Transdermal delivery of a melanotropic peptide hormone analogue
B V Dawson, M E Hadley, K Kreutzfeld, et al.
Page
of 16
Search research articles
Search
Showing results (131-140 of 156) with videos related to
Sort By:
Page
of 16
Journal of the National Cancer Institute
|
August 19, 1992
Antiproliferative and antitumor activity of the 2-cyanoaziridine compound imexon on tumor cell lines and fresh tumor cells in vitro
E M Hersh, C R Gschwind, C W Taylor, et al.
Journal of the American Chemical Society
|
July 18, 2001
Design and synthesis of a novel DNA-DNA interstrand adenine-guanine cross-linking agent
Q Zhou, W Duan, D Simmons, et al.
Life Sciences
|
January 1, 1996
Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study
R T Dorr, R Lines, N Levine, et al.
Journal of Medicinal Chemistry
|
February 13, 1999
Novel antitumor 2-cyanoaziridine-1-carboxamides
B S Iyengar, R T Dorr, D S Alberts, et al.
Journal of Medicinal Chemistry
|
April 12, 1996
6- and 7-substituted 2-[2'-(dimethylamino)ethyl]-1,2-dihydro-3H-dibenz[de,h] isoquinoline-1,3-diones: synthesis, nucleophilic displacements, antitumor activity, and quantitative structure-activity relationships
S M Sami, R T Dorr, A M Sòlyom, et al.
European Journal of Immunology
|
May 1, 1989
Alpha-globulins suppress human leukocyte tumor necrosis factor secretion
P Scuderi, R T Dorr, J D Liddil, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1992
Cardiotoxicity of mitomycin A, mitomycin C, and seven N7 analogs in vitro
R T Dorr, N G Shipp, J D Liddil, et al.
Journal of Medicinal Chemistry
|
August 1, 1987
New antitumor agents containing the anthracene nucleus
T P Wunz, R T Dorr, D S Alberts, et al.
Anti-Cancer Drugs
|
February 1, 1991
In vitro cytotoxicity against fresh human tumors and P388 leukemia predicts the differential in vivo activity of a series of anthracene anticancer drugs
D S Alberts, R T Dorr, T P Wunz, et al.
Life Sciences
|
January 1, 1988
Transdermal delivery of a melanotropic peptide hormone analogue
B V Dawson, M E Hadley, K Kreutzfeld, et al.
Page
of 16